- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Allon Therapeutics Inc
+ Add to WatchlistNPCUF:US
0.0036 USD 0.0074 67.27%As of 09:36:05 ET on 05/21/2013.
Snapshot for Allon Therapeutics Inc (NPCUF)
| Open: | 0.0036 | Day's Range: | 0.0036 - 0.0036 | Volume: | 32,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0110 | 52wk Range: | 0.0001 - 0.5250 | 1-Yr Rtn: | -98.54% |
Key Statistics for NPCUF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 39,284 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NPCUF
Company Profile & Key Executives for NPCUF
Allon Therapeutics Inc. is a drug discovery and development company focused on diseases and conditions of the central nervous system. The Company is developing novel neuroprotective central nervous system therapeutics with lead indications of Alzheimer's Disease and cognitive impairment.
| Gordon C McCauleyPresident/CEO | Matthew J CarlyleVP:Finance/CFO/Secretary |
| Alistair StewartVP:Commercial Research | Bruce H MorimotoVP:Drug Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NPCUF News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page